Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Froehner
Fischer
Wirth

Cancer

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer|December 24, 1997
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?T M Behr, S Gratz, P M Markus, et al.
Cancer|May 13, 2016
Refinement and revalidation of the demoralization scale: The DS-II-internal validitySophie Robinson, David W Kissane, Joanne Brooker, et al.
Cancer|January 10, 2018
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer SystemJames K R Stevenson, Matthew C Cheung, Craig C Earle, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
Cancer|March 7, 2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisisStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.
Cancer|September 8, 2011
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinomaAna M Molina, Darren R Feldman, Martin H Voss, et al.
Cancer|August 19, 2007
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cellsMichael W N Deininger, Jorge Cortes, Ron Paquette, et al.
Cancer|February 9, 2022
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancerConnor J O'Boyle, Giulia Siravegna, Shohreh Varmeh, et al.
Cancer|November 2, 2018
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)Daniel Morgensztern, Manuel Cobo, Santiago Ponce Aix, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer|December 24, 1997
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?T M Behr, S Gratz, P M Markus, et al.
Cancer|May 13, 2016
Refinement and revalidation of the demoralization scale: The DS-II-internal validitySophie Robinson, David W Kissane, Joanne Brooker, et al.
Cancer|January 10, 2018
Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer SystemJames K R Stevenson, Matthew C Cheung, Craig C Earle, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
Cancer|March 7, 2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisisStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.
Cancer|September 8, 2011
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinomaAna M Molina, Darren R Feldman, Martin H Voss, et al.
Cancer|August 19, 2007
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cellsMichael W N Deininger, Jorge Cortes, Ron Paquette, et al.
Cancer|February 9, 2022
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancerConnor J O'Boyle, Giulia Siravegna, Shohreh Varmeh, et al.
Cancer|November 2, 2018
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)Daniel Morgensztern, Manuel Cobo, Santiago Ponce Aix, et al.
Pageof 9